NEWS
May 21, 2026

SSRP Institute Welcomes GuardianMD as New Trusted Partner

PARTNER ANNOUNCEMENT

WILLOUGHBY, Ohio, [May 21, 2026] — The SSRP Institute announces that GuardianMD has joined its Trusted Partner Network following nomination and completion of the SSRP’s internal review process.

GuardianMD is a healthcare services organization focused on physician collaboration and medical direction. It also provides telemedicine clearance services for healthcare practices. The company supports clinics with compliance-related processes and oversight structure. GuardianMD’s model includes operational infrastructure intended to support both practices and collaborating physicians. Its work is centered on helping these relationships function within applicable regulatory requirements.

As the nominating SSRP Member, Darren Frank, CEO of Infusive said: “GuardianMD is helping redefine what compliant growth can look like within the wellness and optimization space. Their physician network, operational infrastructure, and compliance-first approach give clinics the foundation needed to scale responsibly while prioritizing patient safety and quality care. At Infusive, when we see a clinic partnered with GuardianMD, we know they’re serious about compliance and quality oversight, and that matters. We’re excited to support the impact GuardianMD continues to make across the industry and within the SSRP community.”

For SSRP Members, this partnership adds a vetted resource in physician oversight and medical direction. It also offers support in areas related to compliance and practice structure. GuardianMD’s services align with the operational needs of practices navigating state-specific requirements. They also address documentation and collaboration workflows that may be part of day-to-day practice operations.

“SSRP has built an incredible community of clinicians who are passionate about advancing wellness medicine responsibly and ethically,” said Dr. Chris Seitz, Founder and CEO of GuardianMD. “As more nurses, nurse practitioners, and wellness providers enter this space, the need for compliant medical oversight and operational infrastructure becomes increasingly important. We’re proud to support SSRP members with physician collaboration, telemedicine clearance services, and scalable compliance solutions that allow practices to grow with confidence.”

Through these partnerships, the SSRP aims to support Members by connecting them with vetted resources that complement training, protocol development, and implementation in practice.

For more information and to view the GuardianMD Partner Page, visit:
SSRP GuardianMD Partner Page


About the SSRP Institute

The SSRP Institute is an education-focused organization dedicated to advancing cellular medicine through evidence-based training, professional collaboration, and clinically relevant research. SSRP supports providers worldwide through certifications, events, and ongoing educational programming designed to improve patient outcomes and elevate the standard of care.

The SSRP Trusted Partner Network is invitation-only and based on real-world clinical relevance, thoughtful nomination, and alignment with SSRP’s educational principles. Partners are integrated through a structured process designed to foster collaboration, support clinician education, and strengthen the implementation of cellular medicine practices.

RELATED RESOURCES

Continue exploring related topics.

VIEW ALL
ARTICLE
William Seeds, MD
Aug 6, 2026
A Lipid at the Root of Mitochondrial Aging: Phosphatidylcholine, Methylation, and a Malleable Therapeutic Window
William Seeds, MD Aug 6, 2026
A Lipid at the Root of Mitochondrial Aging: Phosphatidylcholine, Methylation, and a Malleable Therapeutic Window
Mitochondrial dysfunction is one of the most firmly established hallmarks of aging, but the field has spent far more energy describing genetic causes of mitochondrial failure—mtDNA mutation, defective OXPHOS, impaired unfolded protein response—than the “natural” drivers that erode mitochondria during ordinary aging. As I discussed in my recent June Journal Club (as well as a […]
READ ARTICLE
VIDEO
Cellular Medicine Mondays
Aug 3, 2026
Ep. 099 - Dr. Seeds’ Office Hours
Preview Only
Dr. Seeds’ Office Hours – Episode 099

Dr. Seeds’ Office Hours – Episode 099

This special edition of Office Hours features questions submitted during the Peptide World Congress Virtual Summit on July 10 and 11. Dr. Seeds and Dr. Newman address:

  1. GLOW Stack, MOTS c, and Thyroid Function (0:50)
  2. Should the GLOW Stack Be Separated? (3:31)
  3. Peptides in Transplant Medicine (8:02)
  4. Biomarker Monitoring (13:21)
  5. Peptides in Acute and Long Term Stroke Recovery (17:37)
  6. Autoimmunity and the GI Tract (23:00)
  7. Cancer Concerns Related to Hormones and Angiogenesis (26:49)

Thank you to Dr. Seeds and Dr. Newman for their expertise, and to our community for participating!

Preview Only — Become a member for full access
VIDEO
Cellular Medicine Mondays
Jul 27, 2026
Ep. 098 - Pentosan Polysulfate: Dosing, Safety, and Monitoring
Preview Only
Dissecting Protocols – Episode 098

Pentosan Polysulfate: Dosing, Safety, and Monitoring

Dr. Seeds examines the subcutaneous use of pentosan polysulfate, addressing concerns about injection site scarring and ocular safety. He discusses dosing, site rotation, cumulative exposure, retinal screening, and strategies for responsible, individualized treatment.(Question Link)

Preview Only — Become a member for full access
SSRP Institute Jul 24, 2026
PCAC Meeting Vote Summary
BREAKING NEWS JULY 24, 2026 – The Pharmacy Compounding Advisory Committee (PCAC) has completed its July session, voting on several peptide bulk drug substances for potential inclusion on the FDA’s 503A Bulks List.Recommended FOR inclusion: (Yes-No)• BPC-157 (8–6)• KPV (8–6)• TB-500 (8–6)• MOTS-c (7–5)• Epitalon (7–4)• Semax (8–5)Recommended AGAINST inclusion: (Yes-No)• DSIP (6–7) What happens […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Jul 20, 2026
Ep. 097 - Creatine: Evidence, Pathways, and Hype
Preview Only
Rabbit Holes – Episode 097

Creatine: Evidence, Pathways, and Hype

Dr. Seeds examines creatine through a cellular medicine lens, separating evidence-supported uses in ATP buffering, performance, and methylation from claims that exceed current clinical data.

Preview Only — Become a member for full access
ARTICLE
William Seeds, MD
Jul 14, 2026
The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Blood Pressure Regulation
William Seeds, MD Jul 14, 2026
The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Blood Pressure Regulation
After a recent Journal Club episode in which I featured, The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Cardiovascular Regulation, I wanted to return to the article and expand a bit on the significance of the Renin–Angiotensin–Aldosterone System (RAAS). As we know, the RAAS system has traditionally been viewed as the body’s primary mechanism for regulating blood pressure, […]
READ ARTICLE
World Congress World Congress
Peptide World Congress 2026
At Peptide World Congress 2026, join the fastest-growing community of evidence-based providers exploring the therapeutic power of clinical peptides. Learn why the body ages, when disease originates, and how top clinicians are changing their patients’ lives by treating the body...
22 Lessons
13 Hours 10 Minutes
View Course
VIDEO
Cellular Medicine Mondays
Jul 13, 2026
Ep. 096 - Stem Cells Derived from The Plucked Hair Follicle
Preview Only
Journal Club – Episode 096

Efficient Generation of Pancreatic Progenitor Cells from Induced Pluripotent Stem Cells Derived from a Non-Invasive and Accessible Tissue Source—The Plucked Hair Follicle

Dr. Seeds reviews how cryopreserved hair follicles may offer a simpler, non-invasive source for future stem cell research and pancreatic cell development. (Article Link)

Preview Only — Become a member for full access
VIDEO
Cellular Medicine Mondays
Jul 6, 2026
Ep. 095 - Dr. Seeds’ Office Hours
Preview Only
Dr. Seeds’ Office Hours – Episode 095
Preview Only — Become a member for full access
ARTICLE
Scott Sherr, MD
Jul 2, 2026
Methylene Blue: From Cellular Energy to Clinical Practice
Scott Sherr, MD Jul 2, 2026
Methylene Blue: From Cellular Energy to Clinical Practice
Scott Sherr, MD | Lucía González Forte, PhD  Submitted for publication [Article] to the SSRP Institute Abstract Methylene blue (MB) is a century-old compound whose renewed relevance in clinical medicine reflects a clearer understanding of its role in mitochondrial function, redox biology, and neuroinflammatory signaling. At therapeutic oral doses, MB acts as a catalytic electron […]
READ ARTICLE

Subscribe to the SSRP Community Digest

Get the latest research and developments in the field of Cellular Medicine straight to your inbox every month.

This field is for validation purposes and should be left unchanged.